INmune Bio price target raised to $23 from $22 at Scotiabank [Yahoo! Finance]
INmune Bio Inc. - Common stock (INMB)
Company Research
Source: Yahoo! Finance
In This Article INMB https://www.tipranks.com/news/the-fly/inmune-bio-price-target-raised-to-23-from-22-at-scotiabank Scotiabank raised the firm's price target on INmune Bio ( INMB ) to $23 from $22 and keeps an Outperform rating on the shares. The company's management appears confident a Biologics License Application that will be filed with the FDA around the end of the year will be received positively, the analyst tells investors. Additionally, the firm believes a positive outcome of the XPRo Phase 2 trial is expected to read out in June, which would “completely dwarf” the CORDStrom commercial opportunity. Maximize Your Portfolio with Data Driven Insights: Leverage the power of TipRanks' Smart Score , a data-driven tool to help
Read more
Impact Snapshot
Event Time:
INMB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INMB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INMB alerts
High impacting INmune Bio Inc. - Common stock news events
Weekly update
A roundup of the hottest topics
INMB
News
- INmune Bio Inc. Presents Baseline Demographics and Disease Profiles of Participants in the MINDFuL Phase II Study [Yahoo! Finance]Yahoo! Finance
- INmune Bio Inc. Presents Baseline Demographics and Disease Profiles of Participants in the MINDFuL Phase II StudyGlobeNewswire
- INmune Bio Inc. Announces Year End 2024 Results and Provides a Business UpdateGlobeNewswire
- INmune Bio Inc. to Report Fourth Quarter 2024 Financial Results and Provide Corporate Update on March 27, 2025 [Yahoo! Finance]Yahoo! Finance
- INmune Bio Inc. to Report Fourth Quarter 2024 Financial Results and Provide Corporate Update on March 27, 2025GlobeNewswire
INMB
Earnings
- 10/31/24 - Miss
INMB
Sec Filings
- 4/1/25 - Form 8-K
- 3/27/25 - Form 8-K
- 3/27/25 - Form 10-K
- INMB's page on the SEC website